Microarray Technologies Drag Down Harvard Bioscience Q1 Financial Report | GenomeWeb

There was no joy found in the executive suites at Harvard Bioscience on Thursday when the company reported its first-quarter financials in a conference call with analysts.

The 450-employee Holliston, Mass.-based company, which sells reagents and lab supplies through catalogs and e-mail, reported an increase in its receipts to $22.2 million with a net loss of $51,000, compared to $19.5 million in revenue and a net gain of $776,000 for the same quarter in 2003.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.